Skipping genetic counseling before or after taking a remote screening of inherited risk for ovarian or breast cancer does not increase distress, anxiety or depression, according to a study published Sept. 14 in JAMA Oncology.
of the two cancers. Some received pre- and post-test counseling, and some did not. Participants rated their distress and anxiety levels before and after testing. Everyone who had a positive finding of increased risk received post-test counseling. Women who did not have a finding of higherThis research was part of the three-year project called
The more diverse populations who needed testing at that time were notably absent, she said. Today, HIV screening can be obtained at your local pharmacy or walk-in clinic. No counseling required.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Rates of sexual dysfunction high in patients with schizophreniaThere is a high prevalence of sexual dysfunction among individuals with schizophrenia, according to a review published online Sept. 13 in JAMA Psychiatry.
Read more »
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastomaAn innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.
Read more »
Adaptive platform trial shows promise for finding new glioblastoma therapiesAn innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.
Read more »
HRQoL consistently high for out-of-hospital cardiac arrest survivorsFor survivors of out-of-hospital cardiac arrest, long-term health-related quality of life is consistently high up to 20 years after the event, according to a study published online Sept. 13 in JAMA Cardiology.
Read more »
Social media may be used to combat COVID vaccine hesitancy in NigeriaA social media campaign launched in 2022 helped encourage some Nigerians to roll up their sleeves for a COVID vaccine, according to a new study published Sept. 15. The paper, 'Outcomes of a social media campaign to promote COVID-19 vaccination in Nigeria,' was published Sept. 15 in the journal PLOS ONE.
Read more »